Busy. Please wait.
or

show password
Forgot Password?

Don't have an account?  Sign up 
or

Username is available taken
show password

why


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.
We do not share your email address with others. It is only used to allow you to reset your password. For details read our Privacy Policy and Terms of Service.


Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.

Remove ads
Don't know
Know
remaining cards
Save
0:01
To flip the current card, click it or press the Spacebar key.  To move the current card to one of the three colored boxes, click on the box.  You may also press the UP ARROW key to move the card to the "Know" box, the DOWN ARROW key to move the card to the "Don't know" box, or the RIGHT ARROW key to move the card to the Remaining box.  You may also click on the card displayed in any of the three boxes to bring that card back to the center.

Pass complete!

"Know" box contains:
Time elapsed:
Retries:
restart all cards




share
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how

Pharm Terms ch2

TermDefinition
Formulary first standard list of drugs and drug recipes used by pharmacists
Pharmacopoeia summarizes standard of drug purity, strength, and directions for synthesis
Excipients inactive ingredients
Black box warnings primary alerts for extreme adverse reactions
Preclincal investigation laboratory research testing on human and microbial cells
FDA's Critical Path Initiative effort to modernize the sciences to enhance the use of bioinformation to improve safety and effectiveness.
Clinical investigation second phase of drug testing - has three stages of of trials
Clinical phase trials longest part of drug approval process - perform tests on volunteers to determine adverse effects
New Drug Application (NDA) must be submitted before a drug is allowed to proceed
Investigational New Drug (IND) may be submitted for Phase I clinical trials when there are significant therapeutic benefits and safe for humans
New Drug Application (NDA) review third phase of drug approval process; trade name is finalized
Postmarketing surveillance final phase of drug approval process; purpose is to survey for harmful drug effects in a larger population
Dependence physiological or psychological need for a substance
Physical dependence altered physical condition when the drug is no longer available
Psychologically dependent intense desire to continue drug use
Controlled substance use is restricted by the Controlled Substance Act
Scheduled drugs 5 classifications according to their potential for abuse
Schedule I Drugs highest potential for abuse
Schedule V Drugs lowest potential for abuse
Teratogenic risk drugs that have potential to harm fetus; categories A, B, C, D, X
Category X Teratogenic drug poses most danger to fetus